Kit de prueba rápida de anticuerpos neutralizantes SARS-CoV-2 (TRFIA)

Información básica

• Disponible en:
• English
• Español

The SARSCoV2 IgG/IgM Rapid Test Kit is an advanced immunoassay tool designed for the detection of antibodies (IgG/IgM) specific to SARSCoV2, the virus responsible for the COVID-19 pandemic. This innovative membrane strip-based kit has been developed to deliver accurate and rapid results for diagnosing SARSCoV2 infections in human whole blood, serum, and plasma samples.

The test kit comprises several key components. Firstly, a burgundy-colored conjugate pad is included, which contains SARSCoV2 recombinant envelope antigens conjugated with Colloid gold (SARSCoV2 conjugates). These conjugates play a crucial role in the test by facilitating the binding of specific antibodies to SARSCoV2 antigens.

Additionally, the kit includes a nitrocellulose membrane strip, which features two distinct test lines - an IgG line and an IgM line - as well as a control line (C line). The IgM line has been pre-coated with the Mouse antiHuman IgM antibody, whereas the IgG line has been coated with Mouse antiHuman IgG antibody. These lines act as indicators for the presence of SARSCoV2-specific antibodies in the tested sample.

By utilizing this test kit, healthcare professionals can obtain reliable results in a timely manner. The presence of IgG antibodies signifies a past or recent SARSCoV2 infection, while the presence of IgM antibodies indicates an active or recent infection. The control line ensures the validity of the test results.

Overall, the SARSCoV2 IgG/IgM Rapid Test Kit is an essential tool in the healthcare industry, enabling efficient and accurate diagnosis of SARSCoV2 infections. It empowers healthcare professionals to identify infected individuals quickly, facilitating prompt and appropriate treatment and ultimately contributing to the control and prevention of the spread of COVID-19.